The debate revealed fundamental uncertainty about whether HSP70/HSP90 systems can distinguish pathological seeds from normal misfolded intermediates. This selectivity is crucial for therapeutic reprogramming strategies but remains mechanistically unclear.
Source: Debate session sess_SDA-2026-04-08-gap-pubmed-20260406-062207-b800e5d3 (Analysis: SDA-2026-04-08-gap-pubmed-20260406-062207-b800e5d3)
The recognition and remodeling of amyloidogenic protein species involves a sequential conformational templating mechanism mediated by HSP90-HSP70 heterocomplexes, where HSP90 serves as the primary conformational sensor while HSP70 provides the refolding machinery. This mechanism centers on HSP90's unique ability to bind partially folded client proteins through its middle domain, which recognizes the altered global fold topology that occurs when amyloidogenic segments become exposed. Upon HSP90 binding, the chaperone induces a conformational change that further exposes the cryptic β-sheet propensity regions, creating high-affinity binding sites for HSP70 recruitment through the co-chaperone HOP (HSP70-HSP90 organizing protein).
...
The recognition and remodeling of amyloidogenic protein species involves a sequential conformational templating mechanism mediated by HSP90-HSP70 heterocomplexes, where HSP90 serves as the primary conformational sensor while HSP70 provides the refolding machinery. This mechanism centers on HSP90's unique ability to bind partially folded client proteins through its middle domain, which recognizes the altered global fold topology that occurs when amyloidogenic segments become exposed. Upon HSP90 binding, the chaperone induces a conformational change that further exposes the cryptic β-sheet propensity regions, creating high-affinity binding sites for HSP70 recruitment through the co-chaperone HOP (HSP70-HSP90 organizing protein). The HSP90-HSP70 heterocomplex then orchestrates a coordinated ATP-dependent cycle where HSP90's conformational constraint maintains the substrate in a refolding-competent state while HSP70 directly engages the exposed amyloidogenic segments. This templating mechanism explains the enhanced specificity for pathological conformers, as HSP90's client selectivity is determined by global structural perturbations that accompany amyloidogenic segment exposure, while normal folding intermediates lack the sustained conformational alterations required for stable HSP90 engagement. The co-chaperones DNAJB6 and DNAJB2 facilitate this process by stabilizing the heterocomplex and enhancing the cooperative binding to amyloidogenic sequences. This model predicts that HSP90 inhibition would impair the recognition of amyloidogenic species by disrupting the initial conformational sensing step, leading to reduced HSP70 recruitment and compromised quality control of aggregation-prone proteins.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
flowchart TD
A["HSPA8, HSPA1A, DNAJB6, DNAJB2 Hypothesis Target"]
B["Aggregation Cited Mechanism"]
C["Cellular Response Stress or Clearance Change"]
D["Neural Circuit Effect Synapse/Glia Vulnerability"]
E["Neurodegeneration Disease-Relevant Outcome"]
A --> B
B --> C
C --> D
D --> E
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style B fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
Median TPM across 13 brain regions for HSP90AA1, HSPA8, HSPA1A, DNAJB6, DNAJB2, STIP1 from GTEx v10.
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
5 citations3 with PMIDValidation: 0%3 supporting / 2 opposing
✓For(3)
No supporting evidence
No opposing evidence
(2)Against✗
HighMediumLow
HighMediumLow
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
5
MECH 5CLIN 0GENE 0EPID 0
Claim
Stance
Category
Source
Strength ↕
Year ↕
Quality ↕
PMIDs
Abstract
HSP70 preferentially binds α-synuclein at N-termin…
HSP70's broad specificity predicts high-affinity binding to any exposed hydrophobic segment—this conflates 'pr…▼
HSP70's broad specificity predicts high-affinity binding to any exposed hydrophobic segment—this conflates 'prefers misfolded' with 'distinguishes pathologic from physiologic misfolded states'
Transient native-state fluctuations expose hydrophobic segments during normal folding—this predicts HSP70 woul…▼
Transient native-state fluctuations expose hydrophobic segments during normal folding—this predicts HSP70 would 'waste' cycles on normal substrates
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-21 | View Analysis
🧬TheoristProposes novel mechanisms and generates creative hypotheses▼
Therapeutic Hypotheses: Chaperone Selectivity for Pathological Conformers
Title: J-protein co-chaperone repertoire enables selective recognition of pathogenic conformers
Mechanism: DNAJB6 (HSP40 family) exhibits selective anti-amyloid activity distinct from DNAJB2, which favors protein refolding. The differential interaction kinetics between specific J-proteins and HSP70 create a "client code" that preferentially engages with the structured β-sheetrich cores of pathological aggregates versus the m
🔍SkepticIdentifies weaknesses, alternative explanations, and methodological concerns▼
Critical Evaluation of Chaperone Selectivity Hypotheses
The "client code" is descriptive terminology lacking mechanistic detail—how do specific J-protein/HSP70 kinetic differences translate to conformational discrimination?
DNAJB6 anti-amyloid activity may reflect kinetic suppression of nucleation rather than selective recognition of pre-formed pathogenic seeds
Overlapping J-protein functionality and redundancy questions whether this provides high-fidelity selectivity
Counter-Evidence:
Germline DNAJB6
🎯Domain ExpertAssesses practical feasibility, druggability, and clinical translation▼
Of the five hypotheses, Hypothesis 3 (amyloidogenic segment recognition) emerges as most feasible for therapeutic development, with a clear mechanism, accessible target, and tractable readouts. Hypothesis 1 (co-chaperone heterogeneity) is mechanistically plausible but presents significant development challenges. Hypothesis 4 (CHIP triage) is supported by strong genetic data but may lack conformational specificity. Hypothesis 2 (CK2-HSP90) is the weakest—too pleiotropic with insufficient validation
⚖SynthesizerIntegrates perspectives and produces final ranked assessments▼
{ "ranked_hypotheses": [ { "title": "Exposed amyloidogenic segments (β-sheet propensity residues) serve as HSP70 recognition codes", "description": "Pathological conformers expose 'aggregation nucleation' sequences—typically 5-15 residue hydrophobic stretches—that are buried in native folds. HSP70 binds these segments with higher affinity due to chronic exposure in misfolded states, explaining apparent 'selectivity' for pathogenic species over transient native-state fluctuations.", "target_gene": "HSPA8, HSPA1A, DNAJB6, DNAJB2", "dimension_scores": { "evid
Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.